Puchner P J, Miller M I
Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York, USA.
J Urol. 1995 Nov;154(5):1779-82.
The efficacy of finasteride was assessed in the treatment of gross hematuria associated with benign prostatic hyperplasia (BPH).
A retrospective review was done of 18 patients who had been placed on finasteride (5 mg . daily) for the treatment of gross hematuria associated with BPH. A hematuria grading system was devised.
Of the 12 patients with longer than 3 months of followup (mean 14) 11 improved according to the grade of hematuria after finasteride therapy.
Finasteride is effective in treating hematuria associated with BPH. This finding is especially relevant for patients with multiple medical problems and anesthetic risks.
评估非那雄胺治疗与良性前列腺增生（BPH）相关的肉眼血尿的疗效。
对18例因BPH相关肉眼血尿而接受非那雄胺（每日5mg）治疗的患者进行回顾性研究。设计了血尿分级系统。
在12例随访时间超过3个月（平均14个月）的患者中，11例在接受非那雄胺治疗后血尿分级有所改善。
非那雄胺对治疗与BPH相关的血尿有效。这一发现对有多种内科问题和麻醉风险的患者尤为重要。
